# Shreya Mehta

> Shreya Mehta is the President and CEO of Zenflow, a South San Francisco medical device company she co-founded in 2014 out of the Stanford Biodesign Innovation Fellowship. A biomedical engineer and former FDA reviewer, she spent a decade building the Zenflow Spring System, a minimally invasive, reversible implant that props open the urethra to relieve symptoms of benign prostatic hyperplasia (BPH). She started as CTO before stepping into the CEO seat, closed a $24M Series C in November 2024, and helped guide the company to FDA approval.

- **Role:** President & CEO at Zenflow, Inc.
- **Organizations:** Zenflow, Inc., Stanford Byers Center for Biodesign, U.S. Food and Drug Administration (former), Ferolyn Fellowship / Fogarty Innovation
- **Nationality:** American
- **Education:** M.S. in Biomedical / Bioengineering, University of Pittsburgh, Thomas Fogarty Biodesign Innovation Fellowship, Stanford Byers Center for Biodesign
- **Known for:** Co-founded Zenflow in 2014 out of the Stanford Biodesign Innovation Fellowship, Guided development of the Zenflow Spring System from concept through FDA approval, Closed a $24M Series C in November 2024 (new investor Cook Medical, plus Invus Opportunities, F-Prime Capital, Medical Technology Venture Partners)

## Career timeline

- **pre-2010** — Worked in the University of Pittsburgh Medical Center's Artificial Heart Program, supporting patients on mechanical cardiac support
- **2010s** — Served roughly four years as a lead scientific reviewer at the FDA, focused on cardiovascular devices, heart valves and artificial hearts
- **2013** — Selected as a Thomas Fogarty Fellow at the Stanford Byers Center for Biodesign, where she met co-founder Nick Damiano
- **2014** — Co-founded Zenflow to develop a minimally invasive treatment for benign prostatic hyperplasia (BPH)
- **2014-2024** — Served as Co-Founder and CTO, leading development of the Zenflow Spring System through clinical trials
- **2024-11** — As CEO, closed a $24 million Series C financing round four days after giving birth
- **2025** — Zenflow received FDA 510(k) clearance for a first-of-its-kind single-use cystoscope
- **2025-12** — Zenflow Spring System received FDA approval for treatment of BPH symptoms

## Achievements

- Co-founded Zenflow in 2014 out of the Stanford Biodesign Innovation Fellowship
- Guided development of the Zenflow Spring System from concept through FDA approval
- Closed a $24M Series C in November 2024 (new investor Cook Medical, plus Invus Opportunities, F-Prime Capital, Medical Technology Venture Partners)
- Raised roughly $84.6M in total funding across the company's life
- Made Zenflow one of the first medical device startups backed by Y Combinator
- Transitioned from Co-Founder/CTO to President & CEO to lead the company's regulatory and commercial phase
- Selected as a Ferolyn Fellow (Fogarty Innovation)

## Latest updates

- **2024-11** — Closed $24 million Series C financing to fund FDA filing and commercial preparation
- **2025-09** — Zenflow received FDA 510(k) clearance for a first-of-its-kind single-use cystoscope
- **2025-12** — Zenflow Spring System received FDA approval for treatment of BPH symptoms; commercialization targeted for 2026

## Links

- Website: https://zenflow.com
- LinkedIn: http://www.linkedin.com/in/shreya-mehta-49a0575
- Twitter/X: http://twitter.com/@zenflowinc
- Facebook: https://facebook.com/zenflowinc

---

Profile page: https://yespress.io/shreya-mehta
Published by YesPress — https://yespress.io
Last updated: 2026-07-29